Still, considering our findings in bladder cancer and theirs in gastric cancer, it is plausible to postulate that blockade of the STAT3 signaling pathway seems to be a general mechanism of sertindole’s anticancer action. The gene discussed is STAT3; the disease is gastric cancer.